New Edge Advisors, LLC Dr Reddys Laboratories LTD Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, New Edge Advisors, LLC holds 235 shares of RDY stock, worth $3,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 47
400.0%
Holding current value
$3,033
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RDY
# of Institutions
264Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$148 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$145 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$130 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$122 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$72.4 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.14B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...